Plasma peptidome: A new approach for assessing thrombotic risk?

Thrombosis and Haemostasis

Volumn 96, Issue 6, 2006, Pages 697-

  Scully, Mike F ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; PROTEIN C; PROTEOME;

ALGORITHM; BLOOD CLOTTING; BLOOD SAMPLING; CANCER; DEEP VEIN THROMBOSIS; EDITORIAL; FEEDBACK SYSTEM; GENETIC PREDISPOSITION; HUMAN; INDIVIDUALIZATION; INFLAMMATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN DEGRADATION; PROTEOMICS; RISK ASSESSMENT; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; THROMBOGENESIS;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGING; BIOLOGICAL MARKERS; HUMANS; PROTEIN C DEFICIENCY; PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VENOUS THROMBOSIS;

EID: 33845361516     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-11-0615     Document Type: Editorial

References (7)

1. Svensson AM, Whitely GR, Callas PW, et al. SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occuring before age 40. Thromb Haemost 2006; 96: 725-30.
2. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer Lancet 2002; 359: 572-7.
3. Nelsestuen GL, Zhang Y, Martinez MB, et al. Plasma protein profiling: unique and stable features of individuals. Proteomics 2005; 5: 4012-24.
4. Villanueva J, Shaffer DR, Philip J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006; 116: 271-84.
5. Hortin GL. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006; 52: 1223-37.
6. Rossi L, Martin BM, Horti GL, et al. Inflammatory protein profile during systemic high dose interleukin-2 administration. Proteomics 2006; 6: 709-20.
7. Richter R, Schulz-Knappe P, Schrader M, et al. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatogr B Biomed Sci Appl 1999; 726: 25-35.